The going public (Stock Launch) of Niva Bupa Health Insurance Company opens up for bidding course of on Thursday, November 7. Investors can bid for the issue within the set value band of Rs 70-74 every for at least 200 fairness shares and its multiples after that. The Stock Launch may be subscribed until Monday, November 11.
Incorporated in 2008, Niva Bupa Health Insurance Company is a joint endeavor in between the Bupa Group and Fettle Tone LLP that provides insurance coverage coverage within the wellness trade. It provides an all pure proposal by giving shoppers accessibility to an in depth wellness neighborhood and answer skills with its Niva Bupa Health cell software and website online.
The Rs 2,200 crore Stock Launch of Niva Bupa Health Insurance consists of a contemporary share sale of Rs 800 crore and an offer-for-sale (OFS) of roughly Rs 1,400 crore by its marketer entities- Bupa Singapore Holdings and Fettle Tone LLP. Net follows the issue will probably be used within the route of enhancement of its funding base to strengthen solvency levels and primary enterprise capabilities.
Niva Bupa Health elevated Rs 990 crore utilizing assist publication because it alloted 13,37,83,783 fairness shares at Rs 74 every. Global financiers consisting of Morgan Stanley, Fidelity, Government Pension Fund Global, Templeton Emerging Markets Investment Trust, First Sentier Investors International, The Scottish Oriental Smaller Companies and others joined the assist publication.
Gurugram- primarily based Niva Bupa Health Insurance Company had 14.73 million energetic lives assured since March 31 2024. The agency exists all through 22 states and 4 union areas in India because the offered day. The complete GWP expanded at a CAGR of 41.27 %, whereas GWP from retail wellness boosted by 33.41 % from FY22 to FY24.
Niva Bupa Health Insurance Company reported a backside line of Rs 18.82 crore with a income of Rs 1,124.90 crore for the quarter upright June 30. The agency clocked an online income of Rs 81.85 crore with a income of Rs 4,118.63 crore for the fiscal yr upright March 31, 2024. The agency will definitely regulate an entire market capitalization of Rs 13,380 crore.
Niva Bupa Health Insurance Company has really scheduled 75 % of the net for the licensed institutional potential consumers (QIBs), whereas non-institutional financiers (NIIs) will definitely acquire 15 % of the deal. Remaining 10 % of the web deal will probably be alloted within the route of the retail financiers.
ICICI Securities, Morgan Stanley India, Kotak Mahindra Capital, Axis Capital, HDFC Bank and Motilal Oswal Investment Advisors are information operating lead supervisors of the Niva Bupa Health Insurance Stock Launch, whereas Kfin Technologies is the registrar for the issue. Here’s what brokerage agency corporations claimed relating to the Stock Launch of Niva Bupa Health Insurance:
Anand Rathi Research
Rating: Subscribe for long-lasting
Niva Bupa Health Insurance is a noticeable medical insurance coverage firm inIndia They present a assorted collection of things for shoppers, enhanced by a strong report in merchandise know-how. Their medical insurance coverage choices are made to fulfill the necessities of shoppers at each section of life, claimed Anand Rathi Research.
“The company aims to build a comprehensive, customer-focused health insurance platform and healthcare ecosystem, offering customers access to a variety of services, including wellness programs, doctor consultations, diagnostics, and medicine delivery. The company is valued at P/BV of 6.1 times. We believe that the issue is fully priced and recommend ‘subscribe for long term,” it claimed.
Arihant Capital Market
Rating: Subscribe for long-term
Niva Bupa Health Insurance has really positioned itself as India’s third greatest and 2nd fastest-growing standalone wellness insurance coverage firm, attaining sturdy GWP improvement The agency concentrates on high-LTV retail wellness objects with an enhancing commonplace ticket dimension and appreciable development in energetic lives assured, claimed Arihant Capital Markets.
Strategic development all through India and digital community improvement, sustained by the e-agency design, extra reinforce its retail wellness market attain. At the highest band of Rs 74, the issue is valued at a PBV proportion of 6.1 occasions primarily based upon a FY24 BV of Rs 12.06 We are advising a ‘subscribe for long-term’ for this downside,” it claimed.
Swastika Investmart
Rating: Subscribe with care
Niva Bupa Health Insurance is a number one gamer in India’s medical insurance coverage market. Among the fastest-growing enterprise within the trade. The agency printed a good turn-around in FY23, although present revenues within the very first quarter of the prevailing financial stay within the hostile. Stock Launch charges exhibits up quite hostile, claimed Swastika Investmart, with excessive hazard financiers to subscribe for the issue.
Canara Bank Securities
Rating: Subscribe for long-term
Gross written prices (GWP) has really expanded at a CAGR of 78.8 % to Rs 5,607.57 crore in FY24. It has really completed a considerable turn-around in web income, increasing at a CAGR of 154.3 %, from a backside line of Rs 196.53 crore in FY22 to an online income of Rs 81.85 crore in FY24, claimed Canara Bank Securities.
“Niva Bupa is a fast-growing health insurer in India, with innovative products, strong market presence, and a solid customer centric approach. However, the aggressive valuation, coupled with the company’s loss-making status in Q1FY25, suggests that the IPO may be suited for investors with a high-risk appetite,” it included with a ‘subscribe’ for long-term rating.
StoxBox
Rating: Subscribe with long-term
Niva Bupa Health Insurance’s financial effectivity is most definitely to be pushed by merchandise know-how, monetary funding in innovation and analytics to assist with the gross sales and upkeep of things and extra improve visibility in current areas inside India, monetary funding in strengthening circulation networks and improve market share in retail medical insurance coverage, claimed StoxBox.
“Given its leading health insurance company, innovative expansion plans, technology-led automated approach and potential for profitability, we recommend a ‘subscribe’ rating for the issue with a medium to long-term investment perspective,” it included.
Mehta Equities
Rating: Subscribe for long-term
Mehta Equities thinks Niva Bupa Health Insurance Stock Launch brings financiers a risk to purchase amongst India’s fastest-growing standalone wellness insurance coverage corporations with a sturdy merchandise profile, calculated know-how and digital improvements. It has really dealt with to reinforce the everyday ticket dimension and increase its circumstances proportion, displaying useful efficiency, claimed Mehta Equities.
“With a CAGR of 41.27 per cent in GWP from FY22-24, Niva Bupa is strategically positioned to capitalize on India’s growing health insurance market. Hence, by looking at all the attributes we recommend investors to ‘subscribe’ the Niva Bupa Health Insurance Company IPO for long term perspective only,” it claimed.
Bajaj Broking
Rating: Subscribe for long-term
Niva Bupa Health Insurance is a number one medical insurance coverage agency in India, dedicated to providing each Indian the self-confidence to entry the perfect well being care. The agency intends to realize this with a wide range of medical insurance coverage product or companies that help shoppers browse their well being care journey, giving accessibility to an in depth wellness neighborhood, claimed Bajaj Broking.
“If we annualize FY25 earnings to the post-IPO fully diluted equity base, the asking price results in a negative price-to-earnings (P/E) ratio. Based on FY24 earnings, the P/E ratio stands at 642.22. Consequently, the issue appears to be aggressively priced,” it claimed with a subscribe for long-lasting rating.
Disclaimer: Business Today offers securities market info for academic capabilities simply and have to not be taken as monetary funding suggestions. Readers are urged to talk with a licensed financial advisor prior to creating any form of monetary funding selections.
